On average, only about half of a random sample of Medicare Part D recipients were adhering to their life-saving heart failure medications – with rates as low as 36 percent in some parts of the U.S.
The findings were made by University of Pittsburgh Graduate School of Public Health associate professor Yuting Zhang, Ph.D., and are reported in the Feb. 11 issue of JAMA Internal Medicine.
“The areas with better adherence could provide a useful benchmark for what is achievable, and system-level quality metrics that incorporate adherence, rather than focusing solely on drug spending, could promote more efficient use of resources,” Dr. Zhang said.
Co-authors of the research letter include Shang-Hua Wu, M.S., Pitt Public Health; A. Mark Fendrick, M.D., University of Michigan School of Public Health; and Katherine Baicker, Ph.D., Harvard School of Public Health.